[en] Atucha 1, a nuclear power plant designed in the late sixties, is in commercial operation since June 1974. In some internal components such as the coolant channels, the station has Stellite-6, a high cobalt content alloy (up to 60%) for hard-facing application. The erosion and corrosion processes on the surfaces of the piping components of the primary coolant and moderator systems generate a varied type of particles oxides called 'crud'. The crud and cobalt 60 produced by neutron activation of cobalt are transferred by the water along the circuit of the coolant and moderator systems, producing deposits on internal surfaces. The cobalt deposits are dominant in radiation fields at working locations. For years, the Authority allowed a considerable number of station workers incurring doses near the limit since that installation had been built previously to introduction of the optimisation concept by ICRP publication 26. The recommendations included in ICRP publication 60 made more than difficult the radiological situation at the Atucha 1. For the facility, to comply with the new limit established by the Authority in January 1995, meant to carry out a substantial modification of the radiological conditions, specially the radiation fields due to cobalt 60. Some options to reduce individual and collective doses were analysed by the Authority. To carry out the evaluation of the deposit mechanisms and the real activity level of cobalt 60, a model of compartments connected by means of constant transfer coefficients was designed. It was concluded that there was a necessity to the change of coolant channels by new ones free of cobalt. It has been shown experimentally that radiation fields and occupational doses were reduced, due to the replacement programme carried out by the utility, in a similar way to the model predictions. At present after more than three years from the beginning of the application of the new limits, and after carrying out partially the tasks for the reduction of the individual doses, this installation complies with dose limits imposed by the Nuclear Regulatory Authority. (author)